Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
0.99
-0.00 (-0.09%)
At close: Jun 12, 2025, 3:59 PM
1.00
1.32%
After-hours: Jun 12, 2025, 05:16 PM EDT
-0.09%
Bid 0.97
Market Cap 58.88M
Revenue (ttm) 10.99M
Net Income (ttm) -57.53M
EPS (ttm) -2.1
PE Ratio (ttm) -0.47
Forward PE -1.94
Analyst Buy
Ask 1.01
Volume 191,117
Avg. Volume (20D) 916,053
Open 0.98
Previous Close 0.99
Day's Range 0.97 - 1.00
52-Week Range 0.65 - 2.18
Beta 0.29

About IRD

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRD
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+9.6%
Opus Genetics shares are trading higher after the ... Unlock content with Pro Subscription
5 months ago
+18.93%
Opus Genetics shares are trading higher after the company announced it secured an FDA agreement under special protocol assessment for its Phase 3 trial of Oral APX3330 in diabetic retinopathy.